Study of memory decline in Alzheimer’s disease
Part of Brain & nervous system, Mental health clinical trials.
This trial studies people diagnosed with Alzheimer’s disease who are at a moderate stage of decline. It likely involves cognitive (memory/thinking) testing and care-partner input to help track changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can speak and understand Cantonese well enough for thinking tests
- A doctor has diagnosed you with Alzheimer’s disease
- Your decline stage fits FAST stage 3 to 5
- You are willing to have blood drawn for the study
- You have a reliable family caregiver who can answer study questions at least monthly
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses digital tools and blood tests to check for early signs of memory problems in healthy older adults living in the community. The goal is to find people who might be at risk for conditions like Alzheimer's disease before symptoms get worse.
This study looks at what factors might predict how quickly memory and thinking skills decline in people with Alzheimer's disease. It uses results from a standard memory test (MMSE) taken at two different times, one year apart, to understand patterns of decline.
This study follows people over time to better understand how memory and thinking complaints progress in early Alzheimer’s disease (from “subjective cognitive decline” to mild cognitive problems). It may help researchers understand who is likely to decline and how symptoms change, which could support future treatments.
This Phase 3 study looks for blood/brain “biomarkers” linked to aging, memory changes, and early brain degeneration. It may help researchers better identify who is at risk and how biology relates to thinking and memory, using brain scans and thinking tests.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This study tests strategies to prevent Alzheimer's disease in people with early memory concerns. It may help if you notice your thinking is not as sharp as before, but you can still manage daily tasks on your own.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.